In Vivo Imaging of β-Galactosidase Activity Using Far Red Fluorescent Switch

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1579-1583

  Tung, Ching Hsuan ^a   Zeng, Qing ^a   Shah, Khalid ^a   Kim, Dong Eog ^a   Schellingerhout, Dawid ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXY 9H (1,3 DICHLORO 9,9 DIMETHYLACRIDIN 2 ONE); ACRIDINE DERIVATIVE; BETA GALACTOSIDASE; BETA GALACTOSIDE; UNCLASSIFIED DRUG; FLUORESCENT DYE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; GENE TRANSFER; GLIOSARCOMA; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; ANIMAL; GENETICS; HERPES SIMPLEX VIRUS 1; HORIZONTAL GENE TRANSFER; LACTOSE OPERON; SENSITIVITY AND SPECIFICITY;

ANIMALS; BETA-GALACTOSIDASE; FLUORESCENT DYES; GENE TRANSFER, HORIZONTAL; HERPESVIRUS 1, HUMAN; LAC OPERON; MICE; SENSITIVITY AND SPECIFICITY;

EID: 1642328231     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3226     Document Type: Article

References (22)

1. Schenborn, E., and Groskreutz, D. Reporter gene vectors and assays. Mol. Biotechnol., 13: 29-44, 1999.
2. Bogdanov, A. A., Jr., and Weissleder, R. In vivo imaging of gene delivery and expression. Trends Biotechnol., 8: S11-S18, 2002.
3. Contag, C. H., and Bachmann, M. H. Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng., 4: 235-260, 2002.
4. Liang, Q., Nguyen, K., Satyamurthy, N., Barrio, J. R., Phelps, M. E., Gambhir, S. S., and Herschman, H. R. Monitoring adenoviral DNA delivery, using a mutant herpes simplex virus type 1 thymidine kinase gene as a PET reporter gene. Gene Ther., 9: 1659-1666, 2002.
5. Berger, F., and Gambhir, S. S. Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer. Breast Cancer Res., 3: 28-35, 2001.
6. Hoffman, R. Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol., 3: 546-556, 2002.
7. Weissleder, R. Scaling down imaging: molecular mapping of cancer in mice. Nat. Rev. Cancer, 2: 11-18, 2002.
8. Rakhmanova, V. A., and MacDonald, R. C. A microplate fluorimetric assay for transfection of the β-galactosidase reporter gene. Anal. Biochem., 257: 234-237, 1998.
9. Young, D. C., Kingsley, S. D., Ryan, K. A., and Dutko, F. J. Selective inactivation of eukaryotic β-galactosidase in assays for inhibitors of HIV-1 TAT using bacterial β-galactosidase as a reporter enzyme. Anal. Biochem., 215: 24-30, 1993.
10. Chilvers, K. F., Perry, J. D., James, A. L., and Reed, R. H. Synthesis and evaluation of novel fluorogenic substrates for the detection of bacterial β-galactosidase. J. Appl. Microbiol., 91: 1118-1130, 2001.
11. Gee, K. R., Sun, W. C., Bhalgat, M. K., Upson, R. H., Klaubert, D. H., Latham, K. A., and Haugland, R. P. Fluorogenic substrates based on fluorinated umbelliferones for continuous assays of phosphatases and β-galactosidases, Anal. Biochem., 273: 41-48. 1999.
12. Sanes, J. R., Rubenstein, J. L., and Nicolas, J. F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J., 5: 3133-3142, 1986.
13. James, A. L., Perry, J. D., Chilvers, K., Robson, I. S., Armstrong, L., and Orr, K. E. Alizarin-β-D-galactoside: a new substrate for the detection of bacterial β-galactosidase. Lett. Appl. Microbiol., 30: 336-340, 2000.
14. Louie, A. Y., Huber, M. M., Ahrens, E. T., Rothbacher, U., Moats, R., Jacobs, R. E., Fraser, S. E., and Meade, T. J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol., 18: 321-325, 2000.
15. Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., and Tung, C. H. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology, 221: 523-529, 2001.
16. Ntziachristos, V., Tung, C. H., Bremer, C., and Weissleder, R. Fluorescence molecular tomography resolves protease activity in vivo. Nat. Med., 8: 757-760, 2002.
17. Weissleder, R., and Ntziachristos, V. Shedding light onto live molecular targets. Nat. Med., 9: 123-128, 2003.
18. Corey, P. F. Chromogenic acridinone enzyme substrates. US Patent 4,810,636. Washington, DC: Patent and Trademark Office, 1989.
19. Corey, P. F., Trimmer, R. W., and Biddlecom, W. G. A new chromogenic β-galactosidase substrates: 7-β -D-galactopyranosyloxy-9,9-dimethyl-9H-acridin- 2-one. Angew. Chem. Int. Ed. Engl., 30: 1646-1648, 1991.
20. Mahmood, U., Tung, C. H., Bogdanov, A., Jr., and Weissleder, R. Near-infrared optical imaging of protease activity for tumor detection. Radiology, 213: 866-870, 1999.
21. Saeki, Y., Fraefel, C., Ichikawa, T., Breakefield, X. O., and Chiocca, E. A. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther., 3: 591-601, 2001.
22. Lampson, L. A., Lampson, M. A., and Dunne, A. D. Exploiting the 1acZ reporter gene for quantitative analysis of disseminated tumor growth within the brain: use of the lacZ gene product as a tumor antigen, for evaluation of antigenic modulation, and to facilitate image analysis of tumor growth in situ. Cancer Res., 53: 176-182, 1993.